Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The utility of cardiovascular imaging in heart failure with preserved ejection fraction: diagnosis, biological classification and risk stratification.

Heart failure reviews - 1 May 2021

Lewis Gavin A, Pearce Keith, Williams Simon G, Schelbert Erik B, Macnab Anita, Miller Christopher A

Abstract excerpt

Heart failure with preserved ejection fraction (HFpEF) does not exist as a singular clinical or pathological entity but as a syndrome encompassing a wide range of clinical and biological phenotypes. There is an urgent need to progress from the unsuccessful 'one-size-fits-all' approach to more precise disease classification, in order to develop targeted therapies, personalise risk stratification and guide future...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular System
Share to Heart Failure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Risk Assessment

Share to Stroke Volume

Source

Open in PubMed Open full text

Identifiers

PMID: 33155067
DOI: 10.1007/s10741-020-10047-9
PMCID: PMC8024231

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The utility of cardiovascular imaging in heart failure with preserved ejection fraction: diagnosis, biological classification and risk stratification.PMID 33155067Read ↗

The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update.Semantic proximity Read ↗

Teasing Apart Heart Failure With Preserved Ejection Fraction Phenotypes With Echocardiographic Imaging: Potential Approach to Research and Clinical Practice.Semantic proximity Read ↗

Echocardiographic Phenomapping in HFpEF: From Imaging Biomarkers to Precision Cardiovascular Medicine.Semantic proximity Read ↗

Myocardial phenotypes and dysfunction in HFpEF and HFrEF assessed by echocardiography and cardiac magnetic resonance.Semantic proximity Read ↗

Clinical Phenogroups in Heart Failure with Preserved Ejection Fraction.Semantic proximity Read ↗

Insight into different phenotypic presentations of heart failure with preserved ejection fraction.Semantic proximity Read ↗

Heart failure with non-reduced ejection fraction: Epidemiology, pathophysiology, phenotypes, diagnosis and treatment approaches.Semantic proximity Read ↗

Reclassifying heart failure: predominantly subendocardial, subepicardial, and transmural.Semantic proximity Read ↗

Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes.Semantic proximity Read ↗

Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment.Semantic proximity Read ↗

Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.Semantic proximity Read ↗

The future of heart failure with preserved ejection fraction : Deep phenotyping for targeted therapeutics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.